Published in Drug Discov Today Dis Mech on July 20, 2011
A computerized prediction model of hazardous inflammatory platelet transfusion outcomes. PLoS One (2014) 0.80
2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium. Transfusion (2015) 0.79
Resveratrol preserves the function of human platelets stored for transfusion. Br J Haematol (2015) 0.77
Improving platelet transfusion safety: biomedical and technical considerations. Blood Transfus (2015) 0.76
Infusible platelet membrane as a platelet substitute for transfusion: an overview. Blood Transfus (2013) 0.75
Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia (2006) 6.45
Platelet activation and atherothrombosis. N Engl J Med (2007) 6.18
Programmed anuclear cell death delimits platelet life span. Cell (2007) 5.98
Platelet transfusions during coronary artery bypass graft surgery are associated with serious adverse outcomes. Transfusion (2004) 2.51
The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg (2008) 2.45
The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med (1994) 2.09
Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion (2007) 1.95
Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood (2005) 1.94
Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J Clin Invest (1997) 1.90
Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med (2008) 1.85
Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol (2005) 1.63
Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 1.58
A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion (1993) 1.52
Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol (1999) 1.50
Structural epitope matching for HLA-alloimmunized thrombocytopenic patients: a new strategy to provide more effective platelet transfusion support? Transfusion (2007) 1.49
Clinical relevance of microparticles from platelets and megakaryocytes. Curr Opin Hematol (2010) 1.43
A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440]. BMC Blood Disord (2004) 1.39
An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion (2006) 1.28
The emerging role of platelets in adaptive immunity. Cell Immunol (2006) 1.19
Beyond hemostasis: the role of platelets in inflammation, malignancy and infection. Cardiovasc Hematol Disord Drug Targets (2008) 1.16
Transfusion-related acute lung injury. Blood Rev (2005) 1.11
Circulating level of microparticles and their correlation with arterial elasticity and endothelium-dependent dilation in patients with type 2 diabetes mellitus. Atherosclerosis (2009) 1.11
The role of ABO matching in platelet transfusion. Eur J Haematol (1993) 1.10
Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion. J Thromb Haemost (2007) 1.10
Blood collection and transfusion in the United States in 1999. Transfusion (2005) 1.10
Basic principles of platelet biology and clinical implications. Circ J (2010) 1.09
Study on the expression of ABH antigens on platelets. Blood (1993) 1.07
Platelet proteome changes associated with diabetes and during platelet storage for transfusion. J Proteome Res (2009) 1.07
Preventing platelet-derived microparticle formation--and possible side effects-with prestorage leukofiltration of whole blood. Arch Pathol Lab Med (2010) 1.00
Platelet apoptosis in stored platelet concentrates and other models. Transfus Apher Sci (2003) 0.98
Cytokine accumulation in photochemically treated and gamma-irradiated platelet concentrates during storage. Transfusion (2006) 0.94
Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusions. Transfus Med (2001) 0.94
Blood group A and B determinants are expressed on platelet glycoproteins IIa, IIIa, and Ib. Thromb Haemost (1991) 0.91
Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study. Transfusion (2010) 0.87
Dynamic role of microparticles in type 2 diabetes mellitus. Curr Diabetes Rev (2009) 0.86
Platelets expressing P-selectin and platelet-derived microparticles in stored platelet concentrates bind to PSGL-1 on filtrated leukocytes. Clin Appl Thromb Hemost (2000) 0.82
Platelet removal from the circulation by the liver and spleen. Am J Physiol (1978) 0.82
The effect of cromoglycate on time-dependent histamine and serotonin concentrations in stored blood products. Transfus Apher Sci (2006) 0.77
Prostaglandins as modulators of immunity. Trends Immunol (2002) 4.15
Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study. Circulation (2013) 3.02
Lactic acid is elevated in idiopathic pulmonary fibrosis and induces myofibroblast differentiation via pH-dependent activation of transforming growth factor-β. Am J Respir Crit Care Med (2012) 2.68
PPARgamma agonists inhibit TGF-beta induced pulmonary myofibroblast differentiation and collagen production: implications for therapy of lung fibrosis. Am J Physiol Lung Cell Mol Physiol (2005) 2.28
Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med (2008) 1.85
Triggers of hospitalization for venous thromboembolism. Circulation (2012) 1.76
Thy-1 expression in human fibroblast subsets defines myofibroblastic or lipofibroblastic phenotypes. Am J Pathol (2003) 1.75
Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab (2002) 1.74
Aryl hydrocarbon receptor-deficient mice develop heightened inflammatory responses to cigarette smoke and endotoxin associated with rapid loss of the nuclear factor-kappaB component RelB. Am J Pathol (2007) 1.72
Transglutaminase 2 and its role in pulmonary fibrosis. Am J Respir Crit Care Med (2011) 1.68
Washing red blood cells and platelets transfused in cardiac surgery reduces postoperative inflammation and number of transfusions: results of a prospective, randomized, controlled clinical trial. Pediatr Crit Care Med (2012) 1.67
CpG oligodeoxynucleotides induce cyclooxygenase-2 in human B lymphocytes: implications for adjuvant activity and antibody production. Clin Immunol (2007) 1.64
The Pseudomonas autoinducer N-(3-oxododecanoyl) homoserine lactone induces cyclooxygenase-2 and prostaglandin E2 production in human lung fibroblasts: implications for inflammation. J Immunol (2002) 1.62
Allogeneic blood transfusions explain increased mortality in women after coronary artery bypass graft surgery. Am Heart J (2006) 1.62
Hospital variation in transfusion and infection after cardiac surgery: a cohort study. BMC Med (2009) 1.58
Cigarette smoke induces cyclooxygenase-2 and microsomal prostaglandin E2 synthase in human lung fibroblasts: implications for lung inflammation and cancer. Am J Physiol Lung Cell Mol Physiol (2004) 1.58
Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. Blood (2004) 1.55
Transfusion of cell saver salvaged blood in neonates and infants undergoing open heart surgery significantly reduces RBC and coagulant product transfusions and donor exposures: results of a prospective, randomized, clinical trial. Pediatr Crit Care Med (2013) 1.55
Autologous transfusion. BMJ (2002) 1.52
Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studies. Transfusion (2009) 1.47
PPAR-γ ligands repress TGFβ-induced myofibroblast differentiation by targeting the PI3K/Akt pathway: implications for therapy of fibrosis. PLoS One (2011) 1.43
Ultrafine particles and platelet activation in patients with coronary heart disease--results from a prospective panel study. Part Fibre Toxicol (2007) 1.43
Aspirin resistance following pediatric cardiac surgery. Thromb Res (2010) 1.42
Large Variation in Blood Transfusion Use After Colorectal Resection: A Call to Action. Dis Colon Rectum (2016) 1.40
The Role of PPARs in Lung Fibrosis. PPAR Res (2007) 1.37
The aryl hydrocarbon receptor attenuates tobacco smoke-induced cyclooxygenase-2 and prostaglandin production in lung fibroblasts through regulation of the NF-kappaB family member RelB. J Biol Chem (2008) 1.37
Fibroblast subsets in the human orbit: Thy-1+ and Thy-1- subpopulations exhibit distinct phenotypes. Eur J Immunol (2002) 1.36
A highly specific phosphatase that acts on ADP-ribose 1''-phosphate, a metabolite of tRNA splicing in Saccharomyces cerevisiae. Nucleic Acids Res (2005) 1.33
Activated human T lymphocytes express cyclooxygenase-2 and produce proadipogenic prostaglandins that drive human orbital fibroblast differentiation to adipocytes. Am J Pathol (2006) 1.32
Electrophilic peroxisome proliferator-activated receptor-gamma ligands have potent antifibrotic effects in human lung fibroblasts. Am J Respir Cell Mol Biol (2009) 1.30
Genetic ablation of the aryl hydrocarbon receptor causes cigarette smoke-induced mitochondrial dysfunction and apoptosis. J Biol Chem (2011) 1.29
A novel anti-inflammatory and pro-resolving role for resolvin D1 in acute cigarette smoke-induced lung inflammation. PLoS One (2013) 1.28
Activated human B lymphocytes express cyclooxygenase-2 and cyclooxygenase inhibitors attenuate antibody production. J Immunol (2005) 1.28
An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion (2006) 1.28
Biochemical genomics approach to map activities to genes. Methods Enzymol (2002) 1.26
The platelet as an immune cell-CD40 ligand and transfusion immunomodulation. Immunol Res (2009) 1.25
Isolation and phenotypic characterization of lung fibroblasts. Methods Mol Med (2005) 1.24
Functional synergy between CD40 ligand and HIV-1 Tat contributes to inflammation: implications in HIV type 1 dementia. J Immunol (2007) 1.22
Transfusion immunomodulation--the case for leukoreduced and (perhaps) washed transfusions. Blood Cells Mol Dis (2012) 1.22
More than structural cells, fibroblasts create and orchestrate the tumor microenvironment. Immunol Invest (2006) 1.21
Unique attributes of orbital fibroblasts and global alterations in IGF-1 receptor signaling could explain thyroid-associated ophthalmopathy. Thyroid (2008) 1.21
Autologous T-lymphocytes stimulate proliferation of orbital fibroblasts derived from patients with Graves' ophthalmopathy. Invest Ophthalmol Vis Sci (2005) 1.20
Specialized proresolving mediators enhance human B cell differentiation to antibody-secreting cells. J Immunol (2012) 1.20
Molecular regulation of cigarette smoke induced-oxidative stress in human retinal pigment epithelial cells: implications for age-related macular degeneration. Am J Physiol Cell Physiol (2009) 1.19
Differential induction of apoptosis by cigarette smoke extract in primary human lung fibroblast strains: implications for emphysema. Am J Physiol Lung Cell Mol Physiol (2006) 1.19
VEGFR-2 inhibition augments cigarette smoke-induced oxidative stress and inflammatory responses leading to endothelial dysfunction. FASEB J (2008) 1.18
Cigarette smoke-induced expression of heme oxygenase-1 in human lung fibroblasts is regulated by intracellular glutathione. Am J Physiol Lung Cell Mol Physiol (2008) 1.17
Determinants of initiation and progression of idiopathic pulmonary fibrosis. Respirology (2009) 1.16
Expression of CD154 (CD40 ligand) by human lung fibroblasts: differential regulation by IFN-gamma and IL-13, and implications for fibrosis. J Immunol (2004) 1.14
Secondary structure models of the 3' untranslated regions of diverse R2 RNAs. RNA (2004) 1.14
Platelets and megakaryocytes contain functional nuclear factor-kappaB. Arterioscler Thromb Vasc Biol (2009) 1.13
Dyad of CD40/CD40 ligand fosters neuroinflammation at the blood-brain barrier and is regulated via JNK signaling: implications for HIV-1 encephalitis. J Neurosci (2010) 1.12
Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb Haemost (2008) 1.12
Ibuprofen and other widely used non-steroidal anti-inflammatory drugs inhibit antibody production in human cells. Cell Immunol (2009) 1.12
New frontiers in transfusion biology: identification and significance of mediators of morbidity and mortality in stored red blood cells. Transfusion (2011) 1.11
An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients. Vox Sang (2011) 1.11
15-deoxy-delta12,14-PGJ2 enhances platelet production from megakaryocytes. Blood (2008) 1.11
Orbital fibroblasts from patients with thyroid-associated ophthalmopathy overexpress CD40: CD154 hyperinduces IL-6, IL-8, and MCP-1. Invest Ophthalmol Vis Sci (2008) 1.10
Lung-targeted overexpression of the NF-κB member RelB inhibits cigarette smoke-induced inflammation. Am J Pathol (2011) 1.08
Platelet proteome changes associated with diabetes and during platelet storage for transfusion. J Proteome Res (2009) 1.07
Prostaglandin D(2), its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells. Immunology (2002) 1.06
Peroxisome proliferator-activated receptor gamma overexpression suppresses growth and induces apoptosis in human multiple myeloma cells. Clin Cancer Res (2008) 1.06
The eye and thyroid disease. Curr Opin Ophthalmol (2008) 1.05
Immune mechanisms in thyroid eye disease. Thyroid (2008) 1.05
Alterations of platelet function and clot formation kinetics after in vitro exposure to anti-A and -B. Transfusion (2012) 1.04
High-dose but not low-dose mainstream cigarette smoke suppresses allergic airway inflammation by inhibiting T cell function. Am J Physiol Lung Cell Mol Physiol (2008) 1.04
15-deoxy-Delta 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway. J Immunol (2002) 1.03
Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists. Clin Immunol (2002) 1.03
Optical effects of anti-TGFbeta treatment after photorefractive keratectomy in a cat model. Invest Ophthalmol Vis Sci (2008) 1.01
Nuclear emancipation: a platelet tour de force. Sci Signal (2010) 1.01
Vascular effects of ultrafine particles in persons with type 2 diabetes. Environ Health Perspect (2010) 1.00
Optimizing platelet transfusion therapy. Blood Rev (2004) 0.98
Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, PPARgamma agonists, differentially regulate cigarette smoke-mediated pro-inflammatory cytokine release in monocytes/macrophages. Antioxid Redox Signal (2008) 0.98
Platelet transfusions: impact on hemostasis, thrombosis, inflammation and clinical outcomes. Thromb Res (2010) 0.97